Nov 18, 2009
NeurogesX To Hold Conference Call To Discuss FDA Approval Of Qutenza(TM) (capsaicin) 8% Patch For Treatment Of Postherpetic Neuralgia (PHN)
NeurogesX, Inc. (Nasdaq: NGSX) announces that it will hold a conference call at 8:30a.m.
| Independent review site since 2002 | : 45,639 product reviews |
Beta Footprint
Learn how we can make a difference...together |
|
Nov 18, 2009
NeurogesX, Inc. (Nasdaq: NGSX) announces that it will hold a conference call at 8:30a.m.